Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase NA 1

Status

Terminated 2Completed 2

Sponsor Class

OTHER 4INDUSTRY 3

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 1CNS 1Breast 1

Conditions

Lymphedema 1Glioma 1Colorectal Neoplasms 1Breast Neoplasms 1

Interventions

Cyclophosphamide 548pembrolizumab 385Radiotherapy 363Bevacizumab 360Carboplatin 351Rituximab 315Cisplatin 300Gemcitabine 297Paclitaxel 288Dexamethasone 272Docetaxel 271fludarabine phosphate 241Doxorubicin 231Nivolumab 220Etoposide 209Cytarabine 203Lenalidomide 201fludarabine 191Oxaliplatin 191Fluorouracil 190Melphalan 189Filgrastim 188Capecitabine 175Calcium Dobesilate 172Radiosurgery 167Erlotinib Hydrochloride 167Methotrexate 163Bortezomib 162Granulocyte Colony-Stimulating Factor 154Whole-Body Irradiation 144

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
OTHER × Has results × Drug Evaluation × Clear all
NCT02538471 2019-12-09

LY2157299 Monohydrate (LY2157299) and Radiotherapy in Metastatic Breast Cancer

Weill Medical College of Cornell University

Phase 2 Terminated
3 enrolled 11 charts
Breast

Breast Neoplasms

NCT01403610 2019-07-24

Safety and Efficacy Study of TH-302 CNS Penetration in Recurrent High Grade Astrocytoma Following Bevacizumab

The University of Texas Health Science Center at San Antonio

Phase 2 Completed
28 enrolled 9 charts
CNS

Glioma

NCT00582660 2017-06-15

UAB0040

University of Alabama at Birmingham

Phase 2 Completed
40 enrolled 7 charts
Gastrointestinal

Colorectal Neoplasms

NCT01893879 2017-05-18

PCTTPL

Stanford University

Phase NA Terminated
14 enrolled 5 charts

Lymphedema

Data powered by HemOnc (CC BY 4.0) Colophon âš¡